Activity value 72china Supplier,Last transaction date:
2025-12-14Address: co ltdthe economic development zonenorth district shengzhou china057583120580
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zhejiang kangmu pharmaceutical co ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 4 transactions, with a transaction quantity of 10000 and a transaction weight of 11240.
YearTransactionsQuantityWeight
2024173900031650
202541000011240
Bill of lading data
<
1/15
>
Trade date
2025/12/14
B/L No.
——
Suppliers
zhejiang kangmu pharmaceutical co ltd.
Buyers
renata plc. changed from renata
Product description
Nguyên liệu làm thuốc thú y: FLORFENICOL (25KG/DRUM), dạng bột, số Lot:FB202409019,FB202409017 NSX:07/09/2024, HSD:06/09/2026.. Hàng mới 100%
Expand
Trade date
2024/08/15
B/L No.
——
Suppliers
zhejiang kangmu pharmaceutical co ltd.
Buyers
renata ltd. change from pfizer
zhejiang kangmu pharmaceutical co ltd. is china Supplier,
and primarily engages in the import and export business of products such as florfenicol,ceftriaxone sodium,entercavir.
According to the 52wmb.com global trade database, as of 2025-12-14, the company has completed 191 international trades,
with its main trading regions covering vietnam,united states,turkey etc.
The core products include HS29414004,HS29414000,HS29419000 etc,
often transported via shanghai,port shanghai cn, port ningbo etc,
and its main trading partners are pecuarius laboratorios s.a.de c.v.,mistav ilaç sanayi ve ticaret anonim şirketi,farmabase saude animal ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zhejiang kangmu pharmaceutical co ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.